NEW YORK, Oct. 22, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning,
Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Vuzix Corporation
(NASDAQ:VUZI), BCE, Inc. (NYSE:BCE), Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH), T2 Biosystems, Inc. (NASDAQ:TTOO), TPG
Specialty Lending, Inc. (NYSE:TSLX), and Jianpu Technology Inc. (NYSE:JT), including updated fundamental summaries, consolidated
fiscal reporting, and fully-qualified certified analyst research.
Complimentary Access: Research Reports
Full copies of recently published reports are available to readers at the links below.
VUZI DOWNLOAD: http://Fundamental-Markets.com/register/?so=VUZI
BCE DOWNLOAD: http://Fundamental-Markets.com/register/?so=BCE
TTPH DOWNLOAD: http://Fundamental-Markets.com/register/?so=TTPH
TTOO DOWNLOAD: http://Fundamental-Markets.com/register/?so=TTOO
TSLX DOWNLOAD: http://Fundamental-Markets.com/register/?so=TSLX
JT DOWNLOAD: http://Fundamental-Markets.com/register/?so=JT
(You may have to copy and paste the link into your browser and hit the [ENTER] key)
The new research reports from Fundamental Markets, available for free download at the links above, examine Vuzix
Corporation (NASDAQ:VUZI), BCE, Inc. (NYSE:BCE), Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH), T2 Biosystems, Inc. (NASDAQ:TTOO),
TPG Specialty Lending, Inc. (NYSE:TSLX), and Jianpu Technology Inc. (NYSE:JT) on a fundamental level and outlines the overall
demand for their products and services in addition to an in-depth review of the business strategy, management discussion, and
overall direction going forward. Several excerpts from the recently released reports are available to today's readers below.
-----------------------------------------
Important Notice: the following excerpts are not designed to be standalone
summaries and as such, important information may be missing from these samples. Please download the entire research report, free of
charge, to ensure you are reading all relevant material information. All information in this release was accessed October 18th,
2018. Percentage calculations are performed after rounding. All amounts in millions (MM), except per share amounts.
-----------------------------------------
VUZIX CORPORATION (VUZI) REPORT OVERVIEW
Vuzix's Recent Financial Performance
For the three months ended June 30th, 2018 vs June 30th, 2017, Vuzix reported revenue of $2.65MM vs $1.33MM (up
99.77%) and analysts estimated basic earnings per share -$0.24 vs -$0.22. For the twelve months ended December 31st, 2017 vs
December 31st, 2016, Vuzix reported revenue of $5.54MM vs $2.13MM (up 160.31%) and analysts estimated basic earnings per share
-$1.02 vs -$1.23. Analysts expect earnings to be released on November 8th, 2018. The report will be for the fiscal period ending
September 30th, 2018. The reported EPS for the same quarter last year was -$0.28. The estimated EPS forecast for the next fiscal
year is -$0.58 and is expected to report on March 15th, 2019.
To read the full Vuzix Corporation (VUZI) report, download it here: http://Fundamental-Markets.com/register/?so=VUZI
-----------------------------------------
BCE, INC. (BCE) REPORT OVERVIEW
BCE's Recent Financial Performance
For the three months ended June 30th, 2018 vs June 30th, 2017, BCE reported revenue of $4,484.15MM vs
$4,238.35MM (up 5.80%) and analysts estimated basic earnings per share $0.61 vs $0.62 (down 1.98%). For the twelve months ended
December 31st, 2017 vs December 31st, 2016, BCE reported revenue of $17,525.44MM vs $16,402.19MM (up 6.85%) and analysts estimated
basic earnings per share $2.41 vs $2.52 (down 4.30%). Analysts expect earnings to be released on November 1st, 2018. The report
will be for the fiscal period ending September 30th, 2018. Reported EPS for the same quarter last year was $0.70. The estimated EPS
forecast for the next fiscal year is $2.81 and is expected to report on February 14th, 2019.
To read the full BCE, Inc. (BCE) report, download it here: http://Fundamental-Markets.com/register/?so=BCE
-----------------------------------------
TETRAPHASE PHARMACEUTICALS, INC. (TTPH) REPORT OVERVIEW
Tetraphase Pharmaceuticals' Recent Financial Performance
For the three months ended June 30th, 2018 vs June 30th, 2017, Tetraphase Pharmaceuticals reported revenue of
$11.58MM vs $1.59MM (up 630.08%) and analysts estimated basic earnings per share -$0.18 vs -$0.83. For the twelve months ended
December 31st, 2017 vs December 31st, 2016, Tetraphase Pharmaceuticals reported revenue of $9.67MM vs $5.15MM (up 87.87%) and
analysts estimated basic earnings per share -$2.63 vs -$2.11. Analysts expect earnings to be released on November 1st, 2018. The
report will be for the fiscal period ending September 30th, 2018. Reported EPS for the same quarter last year was -$0.63. The
estimated EPS forecast for the next fiscal year is -$1.15 and is expected to report on March 5th, 2019.
To read the full Tetraphase Pharmaceuticals, Inc. (TTPH) report, download it here: http://Fundamental-Markets.com/register/?so=TTPH
-----------------------------------------
T2 BIOSYSTEMS, INC. (TTOO) REPORT OVERVIEW
T2 Biosystems' Recent Financial Performance
For the three months ended June 30th, 2018 vs June 30th, 2017, T2 Biosystems reported revenue of $3.93MM vs
$0.96MM (up 311.19%) and basic earnings per share -$0.32 vs -$0.50. For the twelve months ended December 31st, 2017 vs December
31st, 2016, T2 Biosystems reported revenue of $4.67MM vs $4.08MM (up 14.36%) and analysts estimated basic earnings per share -$1.94
vs -$2.11. Analysts expect earnings to be released on November 1st, 2018. The report will be for the fiscal period ending September
30th, 2018. The reported EPS for the same quarter last year was -$0.45.
To read the full T2 Biosystems, Inc. (TTOO) report, download it here: http://Fundamental-Markets.com/register/?so=TTOO
-----------------------------------------
TPG SPECIALTY LENDING, INC. (TSLX) REPORT OVERVIEW
TPG Specialty Lending's Recent Financial Performance
For the three months ended June 30th, 2018 vs June 30th, 2017, TPG Specialty Lending reported revenue of
$66.40MM vs $58.82MM (up 12.89%) and analysts estimated basic earnings per share $0.52 vs $0.53 (down 1.89%). For the twelve months
ended December 31st, 2017 vs December 31st, 2016, TPG Specialty Lending reported revenue of $210.90MM vs $192.41MM (up 9.61%) and
analysts estimated basic earnings per share $1.86 vs $2.34 (down 20.51%). Analysts expect earnings to be released on November 6th,
2018. The report will be for the fiscal period ending September 30th, 2018. The reported EPS for the same quarter last year was
$0.51. The estimated EPS forecast for the next fiscal year is $1.98 and is expected to report on February 20th, 2019.
To read the full TPG Specialty Lending, Inc. (TSLX) report, download it here: http://Fundamental-Markets.com/register/?so=TSLX
-----------------------------------------
JIANPU TECHNOLOGY INC. (JT) REPORT OVERVIEW
Jianpu Technology's Recent Financial Performance
For the twelve months ended December 31st, 2017 vs December 31st, 2016, Jianpu Technology reported revenue of
$222.21MM vs $52.57MM (up 322.70%) and analysts estimated basic earnings per share -$0.23 vs -$0.20. Analysts expect earnings to be
released on December 11th, 2018. The report will be for the fiscal period ending September 30th, 2018. The reported EPS for the
same quarter last year was -$0.03. The estimated EPS forecast for the next fiscal year is $0.04 and is expected to report on March
4th, 2019.
To read the full Jianpu Technology Inc. (JT) report, download it here: http://Fundamental-Markets.com/register/?so=JT
-----------------------------------------
ABOUT FUNDAMENTAL MARKETS
Fundamental Markets serves thousands of members and have provided research through some of the world's leading
brokerages for over a decade–and continue to be one of the best information sources for investors and investment professionals
worldwide. Fundamental Markets' roster boasts decades of financial experience and includes top financial writers, FINRA®
BrokerCheck® certified professionals with current and valid CRD® number designations, as well as Chartered Financial Analyst®
(CFA®) designation holders, to ensure up to date factual information for active readers on the topics they care about.
REGISTERED MEMBER STATUS
Fundamental Markets' oversight and audit staff are registered analysts, brokers, and/or financial advisers
("Registered Members") working within Equity Research, Media, and Compliance departments. Fundamental Markets' roster includes
qualified CFA® charterholders, licensed securities attorneys, and registered FINRA® members holding duly issued CRD® numbers.
Current licensed status of several Registered Members at Fundamental Markets have been independently verified by an outside audit
firm, including policy and audit records duly executed by Registered Members. Complaints, concerns, questions, or inquiries
regarding this release should be directed to Fundamental Markets' Compliance department by Phone, at +1 667-401-0010, or by E-mail
at compliance@Fundamental-Markets.com.
LEGAL NOTICES
Information contained herein is not an offer or solicitation to buy, hold, or sell any security. Fundamental
Markets, Fundamental Markets members, and/or Fundamental Markets affiliates are not responsible for any gains or losses that result
from the opinions expressed. Fundamental Markets makes no representations as to the completeness, accuracy, or timeliness of the
material provided and all materials are subject to change without notice. Fundamental Markets has not been compensated for the
publication of this press release by any of the above mentioned companies. Fundamental Markets is not a financial advisory firm,
investment adviser, or broker-dealer, and does not undertake any activities that would require such registration. For our full
disclaimer, disclosure, and terms of service please visit our website.
Media Contact:
Andrew Duffie, Media Department
Office: +1 667-401-0010
E-mail: media@Fundamental-Markets.com
© 2018 Fundamental Markets. All Rights Reserved. For republishing permissions, please contact a partner network
manager at partnership@Fundamental-Markets.com.
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
FINRA®, BrokerCheck®, and CRD® are registered trademarks owned by Financial Industry Regulatory Authority,
Inc.
